Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.39 |
| ▸ | AMY1A | P0DUB6 | 3/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.38 |
| ▸ | TOP1 | P11387 | 1/20 | 0.35 |
| ▸ | CYCS | P99999 | 2/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9581910 | 0.91 | TERT (0.45) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL29408466 | 0.91 | TERT (0.45) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL5011964 | 0.83 | TERT (0.49) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL479431 | 0.83 | TERT (0.49) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL5016668 | 0.83 | TERT (0.49) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL18578770 | 0.83 | TERT (0.39) | TERTAMY1AABCG2TOP1CYCS | |
| SCHEMBL5015256 | 0.81 | TERT (0.42) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL18593558 | 0.79 | TOP1 (0.45) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL17251726 | 0.79 | TOP1 (0.58) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL5013908 | 0.78 | TERT (0.39) | TERTTOP1CYCSENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100174104-A1 | COBALT-CATALYZED ASYMMETRIC CYCLOPROPANATION WITH DIAZOSULFONES | UNIVERSITY OF SOUTH FLORIDA | 2010-07-08 | — | — | US | disclosed |
| WO-2009114849-A1 | COBALT-CATALYZED ASYMMETRIC CYCLOPROPANATION WITH DIAZOSULFONES | UNIVERSITY OF SOUTH FLORIDA (US) | 2009-09-17 | — | — | WO | disclosed |
| US-7417142-B2 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-7417142-B2 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-7417142-B2 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-20060030718-A1 | Cobalt-based catalysts for the cyclization of alkenes | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-09 | — | — | US | disclosed |
| US-20050124596-A1 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060030718-A1 | Cobalt-based catalysts for the cyclization of alkenes | PPOX, HCCS, ICOSLG | TERT 645/4885AMY1A 2517/4885ABCG2 4619/4885 |
| US-20100174104-A1 | COBALT-CATALYZED ASYMMETRIC CYCLOPROPANATION WITH DIAZOSULFONES | CYCS, TST, CBS | TERT 1829/4885AMY1A 1776/4885ABCG2 3428/4885 |
| US-20050124596-A1 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | PPOX, PPIF, HMBS | TERT 1385/4885AMY1A 1311/4885ABCG2 3295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.